1. Home
  2. NTHI vs RFM Comparison

NTHI vs RFM Comparison

Compare NTHI & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$4.23

Market Cap

109.5M

Sector

Health Care

ML Signal

N/A

Logo RiverNorth Flexible Municipal Income Fund Inc.

RFM

RiverNorth Flexible Municipal Income Fund Inc.

N/A

Current Price

$14.91

Market Cap

89.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NTHI
RFM
Founded
2008
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
109.5M
89.3M
IPO Year
2023
2019

Fundamental Metrics

Financial Performance
Metric
NTHI
RFM
Price
$4.23
$14.91
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
180.6K
8.3K
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$39,990.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$13.68
52 Week High
$12.99
$15.03

Technical Indicators

Market Signals
Indicator
NTHI
RFM
Relative Strength Index (RSI) 54.63 57.33
Support Level $3.01 $14.16
Resistance Level $4.59 $15.03
Average True Range (ATR) 0.44 0.14
MACD 0.10 0.02
Stochastic Oscillator 58.70 81.25

Price Performance

Historical Comparison
NTHI
RFM

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: